KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) EPS (Basic) (2016 - 2025)

Elevance Health (ELV) has disclosed EPS (Basic) for 17 consecutive years, with $2.57 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 37.43% to $2.57 in Q4 2025 year-over-year; TTM through Dec 2025 was $25.28, a 2.05% decrease, with the full-year FY2025 number at $25.28, down 2.05% from a year prior.
  • EPS (Basic) was $2.57 for Q4 2025 at Elevance Health, down from $5.32 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $9.91 in Q2 2024 to a low of $1.87 in Q4 2024.
  • A 5-year average of $6.31 and a median of $6.8 in 2021 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): surged 604.55% in 2021, then tumbled 49.18% in 2024.
  • Elevance Health's EPS (Basic) stood at $4.93 in 2021, then tumbled by 30.02% to $3.45 in 2022, then grew by 6.67% to $3.68 in 2023, then crashed by 49.18% to $1.87 in 2024, then skyrocketed by 37.43% to $2.57 in 2025.
  • Per Business Quant, the three most recent readings for ELV's EPS (Basic) are $2.57 (Q4 2025), $5.32 (Q3 2025), and $7.75 (Q2 2025).